How Washington’s drug-pricing promise could lose its way
Skip to main content
MDHC_Logotype_white
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • This Week's News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • People
    • Regional News
    • Digital Edition
    • Biden admin throws out Texas Medicaid waiver
      Hospitals face specialty pharmacy challenges with insurer competition
      Pandemic propels medical supply companies
      Payers, providers clash over telehealth reimbursement as Congress mulls changes
    • Pandemic propels medical supply companies
      U.S. setting up $1.7B national network to track virus variants
      Next Up Podcast: Managing the COVID-19 vaccination rollout with Dr. Gary Little
      Barbers, artists help defy vaccine myths for people of color
    • Some healthcare associations moving full steam ahead with conferences starting in summer
      COVID hospitalizations in Michigan top fall surge; Beaumont seeing nurse 'burnout'
      Calls mount for Biden to track U.S. healthcare worker deaths from COVID
      Front-line workers want more assistance after a year of COVID-19
    • UnitedHealthcare sees Q1 profits rise and other key earnings takeaways
      California re-opens enrollment for health insurance coverage
      Insurers are partnering to offload the costs of kidney failure patients
      Cigna and Oscar expand their small business partnership
    • Biden admin throws out Texas Medicaid waiver
      J&J vaccine pause a minor blip, but efforts must press on, experts say
      Effort to keep Arkansas Medicaid plan falls short in state Legislature
      A year into pandemic, federal officials design new mask guidelines to better protect more workers
    • Private equity's estimated healthcare spending halved in first quarter
      UH reports $54.7M operating income for 2020 despite significant COVID-related costs
      CMS issues new guidance to enforce price transparency rule
      Massachusetts to crack down on highest-cost hospitals, insurers
    • Bright Health scoops up telehealth startup
      FCC to open next round of COVID-19 telehealth program applications
      CHIME, HLTH to host joint spring conference next year
      Anthem, Blackstone launch new joint venture
    • Michigan expands antibody treatment to cut hospitalizations
      J&J vaccine pause a minor blip, but efforts must press on, experts say
      A year into pandemic, federal officials design new mask guidelines to better protect more workers
      FDA pauses enforcement of in-person dispensing requirement for abortion pill
    • Oscar names new virtual-first care division president
      Redfield joins Big Ass Fans, which promotes controversial COVID-killing technology
      Next Up Podcast: Modern Healthcare's editor Aurora Aguilar talks new content direction
      Novant Health adds chief payor performance officer
    • Midwest
    • Northeast
    • South
    • West
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
    • The Affordable Care Act after 10 years
    • A close-up of a woman receiving a COVID-19 vaccine.
      Providers in underserved communities work toward equitable vaccine distribution
      Josh Bradshaw
      How one rural Illinois county vaccinated 84% of its senior citizens by early March
      Dr. John Fischer
      Patient-reported outcomes tool for hernia surgery helps physicians improve care
      New care model helps primary-care practices treat obesity
    • A family photo of the the Hangens.
      Stressing the already burdened pediatric behavioral health system
      Jennifer Pannone and her daughter Victoria.
      Mental health access for children needs attention
      What's next for on-demand telehealth companies?
      A CalOptima PACE vaccination clinic.
      Will COVID-19 be the catalyst for creating a more sustainable healthcare system?
    • Ryan McGinnis
      Finding efficiencies in the OR using tech
      Dr. Daniel Hall
      UPMC pilots machine learning, telehealth to inform patient transfers
      A woman being recorded using her inhaler on a smartphone.
      Digital check-ins, connected inhalers help control asthma
      A phone screen showing the question, "Mary we hope this information was helpful and we'd like to keep guiding you. Are you interested in knowing when it's your turn to receive the vaccine?"
      Chatbots, texting campaigns help manage influx of COVID vax questions
  • Transformation
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Mayo Clinic launches two tech companies
      Diabetes patients at high risk for COVID-19 are managing conditions more effectively
      Nearly 1 in 5 Americans skipped care due to cost last year
      COVID-19 long-haulers need holistic treatment, providers say
    • Amazon gives out $12M under next phase of AWS diagnostics development initiative
      Malpractice premiums peak in 2020, AMA survey shows
      A rendering of a cancer research institute at the University of Southern California that will include 5G.
      Healthcare providers determine how to best use ultrafast 5G
      Two-thirds of largest hospitals aren't complying with price transparency rule
    • Hospitals face specialty pharmacy challenges with insurer competition
      Addressing long-standing barriers needed for mental and physical health integration
      A close-up of a woman receiving a COVID-19 vaccine.
      Providers in underserved communities work toward equitable vaccine distribution
      The waiting room of a Kaiser Permanente clinic at a Target location.
      Health systems revamp their approach to retail clinics
    • Payers, providers clash over telehealth reimbursement as Congress mulls changes
      When money talks. Why cash pay is becoming more popular
      CMS wants to bump pay for hospices, SNFs next year
      CMMI pauses new Direct Contracting model applications
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
    • Health Systems Financials
      Executive Compensation
      Physician Compensation
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
    • Dr. Alan Kaplan
      The risks, rewards of taking organizations 'where they haven’t gone before'
      Wellstar CEO calls adapting for the pandemic her bold move
      Howard P. Kern
      Recognizing the value of telehealth in its infancy
      Dr. Stephen Markovich
      A bold move helped take him from family doctor to OhioHealth CEO
    • Drs. Hal Paz and Joshua J. Joseph
      Mobilized to fight the COVID crisis: a blueprint for community and academic partnerships
      Dr. Stephen Markovich
      Making sure we're aligned along the path to achieving inclusion
      Barry Ostrowsky
      Ending racism is a journey taken together; the starting point must be now
      Laura Lee Hall and Gary Puckrein
      Increased flu vaccination has never been more important for communities of color
    • It's time we fulfill the ACA's promise to broaden access to lower-cost drugs
      Five lessons for securing our children's future
      We're losing engaged providers, and healthcare will pay the price
      Dr. Chris DeRienzo
      How COVID-19 broke health systems and made them stronger
    • Letters: Eliminating bias in healthcare needs to be ‘deliberate and organic’
      Letters: Maybe dropping out of ACOs is a good thing for patients
      Letters: White House and Congress share blame for lack of national COVID strategy
      Letters: VA making strides to improve state veterans home inspections
    • Sponsored Content Provided By Optum
      How blockchain could ease frustration with the payment process
      Sponsored Content Provided By Optum
      Three steps to better data-sharing for payer and provider CIOs
      Sponsored Content Provided By Optum
      Reduce total cost of care: 6 reasons why providers and payers should tackle the challenge together
      Sponsored Content Provided By Optum
      Why CIOs went from back-office operators to mission-critical innovators
  • Awards
    • Award Programs
    • Nominate
    • Previous Award Programs
    • Other Award Programs
    • Nominations Closed - 50 Most Influential Clinical Executives
      Nominations Open - Top 25 Innovators
      Nominations Open May 24 - Top 25 Emerging Leaders
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Minorities in Healthcare
      • - Luminaries
      • - Top 25 Minority Leaders
      • - Minorities to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Excellence in Nursing Awards
    • Design Awards
    • Top 25 COOs in Healthcare
    • 100 Top Hospitals
    • ACHE Awards
  • Events
    • Conferences
    • Galas
    • Webinars
    • COVID-19 Event Tracker
    • emburse certify modern healthcare custom media webinar logo lockup
      Sponsored Content Provided By Emburse
      Webinar: Making it easy to manage costs
      virtualmed staff modern healthcare custom media logo lockup
      Sponsored Content Provided By VirtualMed Staff
      Webinar: Best practices for creating a successful telepsychiatry program
      telehealth visit man touching neck while speaking to doctor on computer
      Sponsored Content Provided By Accumen
      Webinar: How telehealth has evolved into a standard of care
      modern healthcare custom media and trimedx custom webinar logo lockup
      Sponsored Content Provided By TRIMEDX
      Webinar: Bridging the gap between clinicians and administration to improve capital equipment planning
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Healthcare Transformation Summit
    • Leadership Symposium
    • Virtual Briefings
      • - Hospital of the Future
      • - Mental Health
      • - Patient Safety & Quality
      • - Strategic Marketing
      • - Virtual Health
      • - Workplace of the Future
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Minority Leaders Gala
    • Top 25 Women Leaders Gala
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
    • Next Up Podcast: Managing the COVID-19 vaccination rollout with Dr. Gary Little
      Next Up Podcast: Modern Healthcare's editor Aurora Aguilar talks new content direction
      Dr. Chris DeRienzo
      Next Up Podcast: Building team spirit in the wake of COVID-19
      Mikelle Moore
      Next Up Podcast: Mikelle Moore on recognizing all hospital workers during the pandemic
    • Beyond the Byline: Kids' unchecked mental health needs pose long-term consequences
      Beyond the Byline: How COVID-19 has impacted hospital finances
      An older man sitting on a hospital bed with his back toward the camera.
      Beyond the Byline: Upcoding could explain why hospitals are increasingly billing for the most complex treatment
      Beyond the Byline: Insurers are betting on virtual-first plans as COVID-19 shifts care pathways
    • James garvert neustar healthcare insider podcast image
      Building on basics
      Healthcare Insider Podcast Episode Art - Premier
      Why Roger Weems and other consultants are leaving the big firms to join Premier
      James garvert neustar healthcare insider podcast image
      Outreach during COVID-19
      ann barnes healthcare insider podcast image
      Leading with intention to promote diversity and inclusion
    • The Check Up: Dr. James E.K. Hildreth
      The Check Up: Dr. James E.K. Hildreth of Meharry Medical College
      The Check Up: Matt Eyles
      The Check Up: Matt Eyles of AHIP
      The Check Up: Dr. Tom Shanley
      The Check Up: Dr. Tom Shanley of Lurie Children’s Hospital of Chicago
      The Check Up: Dr. Harold Paz
      The Check Up: Dr. Harold Paz of Wexner Medical Center at Ohio State University
    • ivana naeymi-rad one on one intelligent medical objects
      Video: Ivana Naeymi Rad of Intelligent Medical Objects
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
April 20, 2019 01:00 AM

How Washington’s drug-pricing promise could lose its way

Susannah Luthi
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print
    Drug pricing
    Getty Images/Modern Healthcare Illustration

    Kathy Sego, a choir teacher from Indiana, sat before the Senate Finance Committee in late January and tried to show lawmakers how drastically drug pricing needs to change.

    Sego told senators how her diabetic son secretly rationed his insulin after he realized it cost his insured parents $1,700 per month. She described his sharp and sudden weight loss and spiraling health problems. She explained what it was like to take a trip to Hungary and see a $10 price tag for the same vial of insulin that cost them $487 back home. 

    She detailed how she and her husband each work more than 80 hours per week and stretch out their payments to the point their electricity got cut off so they could buy the medicine.

    Her voice cracked as she laid out her son’s insulin-dependent future. “He wonders—can he pay for an apartment?” Sego said, her voice wavering as she began to cry. “Utility bills? His student loans? Will he be able to have a social life? Take a girl on a date? The thing is, it really comes down to this: Hunter needs insulin to live, but should that need for insulin keep him from living?”

    Then lawmakers and experts got to work. That meant Sego sat for hours mostly in silence, as analysts seated beside her talked about innovation, competition and inflation caps.

    The scene is familiar on Capitol Hill, where the pageantry played out in hearing rooms fades into a cautious dance.

    It’s been nearly four months since an energized Democratic majority in the House started 2019 with promises of sweeping reform of drug prices, supported by the ambitious goals of the Trump administration and milder assurances of the GOP-led Senate. Although lawmakers emphasize that it’s still early in the 116th Congress, and reiterate their agreement to do something big, the window to develop their ideas is narrowing. 

    Leading lawmakers have yet to decide what “something big” would look like. They certainly haven’t cohesively rallied around the boldest Trump administration ideas, such as banning rebates for pharmacy benefit managers and tying high Medicare Part B drug prices to their costs in foreign countries that pay less. And there are plenty of factors in play to shrink Congress’ drug-pricing ambitions down to size.

    Last week brought a fresh reminder of the pharmaceutical industry’s massive war chest and targeted lobbying. Early 2019 fundraising receipts for members of Congress show a trail of pharma donations to key committee leaders.

    An early start

    Top pharmaceutical company donations
    January-March 2019

    Pallone for Congress
    Rep. Frank Pallone Jr. (D-N.J.)
    Chair, House Energy and Commerce Committee

    $2,500 AmerisourceBergen
Corp. PAC
    $2,000 Pfizer PAC
    $1,000 Johnson & Johnson PAC
    $1,000 Amgen PAC

    Richard Neal for Congress
    Rep. Richard Neal (D-Mass.)
    Chair, House Ways and Means Committee

    $2,500 Genentech PAC
    $2,500 Sanofi U.S. Services 
Employees’ PAC
    $2,000 Abbott PAC

    Source: Federal Election Commission filings

    House Energy and Commerce Committee Chair Frank Pallone (D-N.J.), Ways and Means Chair Richard Neal (D-Mass.), and Energy and Commerce Health Subcommittee Chair Anna Eshoo (D-Calif.) collected thousands of dollars from pharma groups and companies.

    That isn’t unusual, as the pharmaceutical industry has traditionally put its money toward committees of influence. 

    But this year, when Democratic leadership has promised regular order to give committee chairs sway over legislation, these chairmanships are as important as ever.

    Pallone’s top pharma contributors in the first quarter of 2019 included Pfizer, AmerisourceBergen, Johnson & Johnson and Amgen. Neal’s contributions came from Abbott, Biogen, Genentech, Sanofi and Merck, among others.

    Eshoo brought in more than $20,000 from Gilead Sciences, Denmark-based Lundbeck, Jazz Pharmaceuticals, Amgen, AbbVie, the Pharmaceutical Research and Manufacturers of America, and executives of some of those firms.

    None of the tallies count money from consulting and lobbying firms that also represent the industry.

    The outlier among the House committee heavyweights is Rep. Lloyd Doggett (D-Texas), who chairs the Ways and Means Committee’s health panel. A vocal pharma critic, he has proposed holding drug patents as leverage to lower prices for Medicare. And manufacturers responded accordingly.

    Still, Doggett has a biotech donor in the Austin-based company Asuragen, whose executives contributed more than $7,000 to his 2020 campaign.

    Major pharma contributions aren’t new for any of these lawmakers—a criticism that followed Eshoo in particular as she assumed the Energy and Commerce Health Subcommittee chairmanship. Her district houses biotech giants and in the last election cycle the industry was her biggest donor, accounting for more than $160,000 of her campaign funds, according to OpenSecrets.org.

    Big Pharma's top donors

    When Pallone was ranking member on Energy and Commerce, pharma gave nearly $250,000 to his campaign for the 2018 cycle. That compares to roughly $414,000 he raised from other health professional groups.

    Neal’s donations were even higher. Last cycle he raised more than $282,000 from the drug industry. That’s in comparison to more than $381,000 from insurers, according to OpenSecrets.

    For context, the former GOP chairs of these same committees were top recipients of pharmaceutical money in the 2018 election cycle, according to an analysis from the Center for Responsive Politics, which operates the OpenSecrets website. Rep. Greg Walden (R-Ore.), then leader of Energy and Commerce, ranked first for pharma contributions to House lawmakers last year, while Rep. Kevin Brady (R-Texas), former chair of Ways and Means, came in fourth. 

    These are the easy-to-track contributions. There’s also so-called dark money, which is funneled through 501(c) organizations and used to advocate policy along ideological arguments.

    The Center for Responsive Politics last November found PhRMA disbursed millions of dollars to dark money groups aligned with Republicans.

    This boosts issues-focused groups to lobby Republicans in Congress against some of the administration’s ideas, notably the international reference-pricing model for Medicare Part B.

    The top 501(c) recipients of PhRMA money included the American Conservative Union, an organization that has been out front in opposition to the reference-pricing proposal.

    Last year PhRMA also gave $1.5 million to the American Action Network—a group that in 2016 spent $2.6 million on an issues campaign against a Medicare Part D negotiation policy.

    Conservative groups are also arguing against ideas like personal importation—bringing $10 insulin back from Hungary, for instance—which Senate Finance Committee Chair Chuck Grassley, a Republican, has supported.

    The other side of the aisle raked in big bucks too: $1.19 million of PhRMA’s contributions went to Center Forward, a group that spent $1.3 million on Democrats for the 2018 midterms. Among the top recipients for Center Forward were the two moderate Democratic House political action committees—the Blue Dogs and the New Democrat Coalition.

    Members of these groups are more sensitive than other Democrats to arguments about “price fixing,” and they also have more power in numbers now. The New Democrat Coalition got an enormous boost in the 2018 midterms, as Democrats took the House through swing districts nabbed by moderates. 

    The other critical influence on how the final drug-pricing legislation will turn out has less to do with money, but is arguably more pressing: the calendar. Grassley said he wants the Senate package wrapped up by June or July, given all that Congress needs to address before the fall—like the debt limit. 

    So far, House committees have approved uncontroversial measures like , a  and the Creates Act, all of which are expected to go to the House floor. Democrats in particular want to go much bigger, yet House Speaker Nancy Pelosi (D-Calif.) has yet to disclose the “flagship” bill that would allow Medicare to negotiate prices in Part D.

    In the vacuum of other Medicare negotiation proposals, progressives in the House have  and plan to take their advocacy for his idea nationwide through Facebook Live town halls. But the idea likely won’t gain traction since it affects the U.S. patent system so drastically, and committee Republicans have made it clear they would never support it.

    This leaves other Democrats hanging, and the conversations about hard-line policy have remained vague.

    Rep. Kurt Schrader (D-Ore.), a leading member of the Blue Dogs and the New Democrat Coalition, said he thinks people want Congress to do something beyond low-hanging fruit, but he couldn’t pinpoint exactly what that is.

    Eshoo was also noncommittal. “I think it’s important to explore all avenues to lower drug prices,” she said, when asked for her view on a policy like arbitration. “I don’t think that lowering drug prices is done by one action.”

    For all the industry influence and time constraints, there’s one more pressure point: 2020. Democrats want to defend their House majority and Republicans have a lot of Senate seats up for a challenge, not to mention the presidency.

    “Republicans and Democrats have got to deliver for the American people on lower prescription drug prices, period,” Rep. Debbie Dingell (D-Mich.) said. “You hear about the cost of insulin wherever you go, from the children to the seniors. So instead of everybody pitting us against each other, we’ve got to find a way to deliver for the people who elected us, or everyone’s in trouble.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    More than a dozen states to open vaccines to all adults
    More than a dozen states to open vaccines to all adults
    Becerra visits Nevada, stumps for pandemic aid and Obamacare
    Becerra visits Nevada, stumps for pandemic aid and Obamacare
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS
    • Instagram

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    MDHC_Logotype_white
    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2021. Crain Communications, Inc. All Rights Reserved.
    • News
      • This Week's News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Transformation
      • Patients
      • Operations
      • Care Delivery
      • Payment
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Award Programs
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Minorities in Healthcare
          • - Luminaries
          • - Top 25 Minority Leaders
          • - Minorities to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Nominate
      • Previous Award Programs
        • Excellence in Nursing Awards
        • Design Awards
        • Top 25 COOs in Healthcare
      • Other Award Programs
        • 100 Top Hospitals
        • ACHE Awards
    • Events
      • Conferences
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Healthcare Transformation Summit
        • Leadership Symposium
        • Virtual Briefings
          • - Hospital of the Future
          • - Mental Health
          • - Patient Safety & Quality
          • - Strategic Marketing
          • - Virtual Health
          • - Workplace of the Future
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Minority Leaders Gala
        • Top 25 Women Leaders Gala
      • Webinars
      • COVID-19 Event Tracker
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing